Will Hims & Hers Health stock break $31.91 resistance as intraday buyers stay active?

Traders Union
All News
Stocks
Hims & Hers Health jumps 7.65% today

Highlights

HIMS/USD trades below key technical averages and faces persistent selling pressure across short, medium, and long-term trends.
Momentum indicators are mixed, with strong sell signals countered by intraday buying attempts and high volatility.
Forecast range is $26.72–$33.76, with a 65% probability of decline and immediate resistance near $31.91.

Divergent oscillator signals as price faces multi-timeframe resistance

On the technical side, HIMS is trading below the MA-20 ($30.44), MA-50 ($31.85), and MA-200 ($30.92) across major timeframes. The Ichimoku Kijun on the daily chart stands at $31.91, acting as immediate resistance. MACD continues to signal strong sell momentum, while ADX remains neutral and suggests weak trend strength. RSI reads 46.78 with a slight sell bias, but does not indicate oversold conditions. Stochastic RSI is overbought, and CCI is neutral. Bull/Bear Power reflects ongoing buyer activity intraday, showing divergence from other mostly bearish momentum indicators. The mix among oscillators highlights a lack of consensus on immediate direction.

Downside risk prevails as resistance holds and volatility persists

In the short term, HIMS is likely to consolidate within a projected range of $26.72 to $33.76, reflecting typical volatility. The probability of an upward breakout stands at 35%, with downside continuation more probable at 65%. If resistance near $31.91 is broken, HIMS could see further gains, while a drop below $26.72 may accelerate selling pressure.

Viktoras Karapetjanc, expert at Traders Union, sees Hims & Hers Health (HIMS) as showing renewed buyer interest despite a lack of supporting news. He notes the price remains below several key moving averages, with mixed signals from momentum indicators. Short-term volatility is high, and more downside remains possible unless resistance at $31.91 breaks. However, he believes the overall setup is constructive and indicates opportunity if momentum shifts. "If the stock can clear $31.91, the path for further gains opens — I expect investor sentiment to turn more positive on any decisive breakout."

Earlier, analysts noted that Hims & Hers Health was experiencing persistent bearish pressure, with technical signals offering mixed guidance on its immediate direction. With the stock still struggling to overcome resistance and most momentum indicators remaining bearish, traders should closely monitor for any decisive move above $31.91 as a trigger for potential trend reversal.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.